Eculizumab for treatment of asthma

TPI ASM8 reduces eosinophil progenitors in sputum after allergen challenge

(2011) H. Imaoka et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS Clinical Trial

(2011) Yuzuru Kanakura et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

A Randomized, Controlled, Phase 2 Study of AMG 317, an IL-4Rα Antagonist, in Patients with Asthma

(2010) Jonathan Corren et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Effects of Interleukin-13 Blockade on Allergen-induced Airway Responses in Mild Atopic Asthma

(2010) Gail M. Gauvreau et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Visual improvement in established central retinal vein occlusion with long-standing macular edema following systemic eculizumab treatment

(2010) David Lockington et al.   CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE

Can inhaled corticosteroids prevent asthma exacerbations?

(2010) Dhananjay Desai et al.   CURRENT OPINION IN PULMONARY MEDICINE

A complex role for complement in allergic asthma

(2010) Xun Zhang et al.   Expert Review of Clinical Immunology

Paroxysmal Nocturnal Hemoglobinuria — Hemolysis before and after Eculizumab

(2010) Antonio M. Risitano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy of eculizumab in a patient with factor-H-associated atypical hemolytic uremic syndrome

(2010) Anne-Laure Lapeyraque et al.   PEDIATRIC NEPHROLOGY

Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma

(2009) Pranabashis Haldar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia

(2009) Parameswaran Nair et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Complement Component 5 Gene and Age-Related Macular Degeneration

(2009) Dominique C. Baas et al.   OPHTHALMOLOGY

Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy

(2009) M Weatherall et al.   THORAX

FDA Report: Eculizumab (Soliris(R)) for the Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria

(2008) A. Dmytrijuk et al.   ONCOLOGIST